A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency

计划入组 22 人 · 首次发布于 2022 年 5 月 4 日

Optimizing Clinical Use of Polymyxin B

计划入组 155 人 · 首次发布于 2016 年 2 月 15 日

Intraventricular Administration of Intracranial Infections Caused by （Carbapenem-resistant Gram-negative Bacilli）CRGNB

计划入组 222 人 · 首次发布于 2024 年 9 月 19 日

Polymyxin B(Casporyn HC, Cortisporin, Dioptrol, Diosporin, Diphen, Maxitrol, Neo-polycin, Neo-polycin HC, Neosporin Ointment, Neosporin Plus Maximum Strength, Neosporin Plus Maximum Strength Cream, Neosporin Solution, Polycin-B, Polysporin, Polytrim, Procomycin, Statrol, Triple Antibiotic)

C₅₆H₉₈N₁₆O₁₃

Hydrocortisone/Polymyxin B Sulfate

Chloramphenicol/Polymyxin B Sulfate

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

Spectral Medical's Tigris Trial Shows Significant Mortality Reduction in Endotoxic Septic Shock, Published in The Lancet

Polymyxin B MIC >1 mg/L Predicts Reduced Clinical Cure and PK/PD Target Attainment in Carbapenem-Resistant Enterobacterales Infections

FDA Grants QIDP Status to Venus Remedies' Novel Antibiotic VRP-034 for Bloodstream Infections